A review of neurological side effects of COVID-19 vaccination
Open Access
- 25 February 2023
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Medical Research
- Vol. 28 (1), 1-8
- https://doi.org/10.1186/s40001-023-00992-0
Abstract
Following the COVID-19 virus epidemic, extensive, coordinated international research has led to the rapid development of effective vaccines. Although vaccines are now considered the best way to achieve collective safety and control mortality, due to the critical situation, these vaccines have been issued the emergency use licenses and some of their potential subsequence side effects have been overlooked. At the same time, there are many reports of side effects after getting a COVID-19 vaccine. According to these reports, vaccination can have an adverse event, especially on nervous system. The most important and common complications are cerebrovascular disorders including cerebral venous sinus thrombosis, transient ischemic attack, intracerebral hemorrhage, ischemic stroke, and demyelinating disorders including transverse myelitis, first manifestation of MS, and neuromyelitis optica. These effects are often acute and transient, but they can be severe and even fatal in a few cases. Herein, we have provided a comprehensive review of documents reporting neurological side effects of COVID-19 vaccines in international databases from 2020 to 2022 and discussed neurological disorders possibly caused by vaccination.Keywords
This publication has 102 references indexed in Scilit:
- COVID-19 vaccination-associated myelitisQJM: An International Journal of Medicine, 2021
- Bell's palsy and SARS-CoV-2 vaccinesThe Lancet Infectious Diseases, 2021
- Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 VaccineCureus, 2021
- Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsyBrain, Behavior, & Immunity - Health, 2021
- Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case reportActa Neurologica Belgica, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2020
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialThe Lancet Infectious Diseases, 2020
- Towards a molecular systems model of coronary artery disease.Current Cardiology Reports, 2014
- The spectrum of post-vaccination inflammatory CNS demyelinating syndromesAutoimmunity Reviews, 2014